Bloomios, Inc. BLMS

BLMS Company Overview

Bloomios, Inc. is a U.S.-based company operating in the cannabinoid wellness, nutraceutical, and consumer packaged goods sectors. The company has focused on the development, manufacturing, and commercialization of products containing hemp-derived cannabinoids, particularly cannabidiol (CBD), as well as wellness-oriented consumer products. Bloomios has historically targeted both business-to-business and direct-to-consumer channels through formulation, white-label manufacturing, and branded product distribution. Public disclosures indicate that the company has also explored broader opportunities in health and wellness product commercialization and strategic acquisitions within adjacent consumer categories.

The company evolved through a series of restructurings and strategic shifts tied to the rapidly changing U.S. hemp and cannabinoid market following the 2018 Farm Bill legalization framework for industrial hemp. Bloomios has sought to differentiate itself through vertically integrated product development capabilities, manufacturing relationships, and emphasis on regulatory-compliant cannabinoid formulations. Public filings and market disclosures indicate that management has periodically adjusted the company’s operating focus in response to evolving consumer demand, regulatory uncertainty, and capital market conditions affecting smaller publicly traded wellness companies.